Form 4 for ARCT Arcturus Therapeutics Holdings Inc.
Accepted 2022-11-28 00:00:00 ET · period of report 2022-11-23 · accession 0001193805-22-001614 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-28 | 2022-11-23 | ARCT | Payne Joseph E | Pres, CEO, Dir | P - Purchase | $16.51 | +5,000 | 1.48M | +0.3% | +$82.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-23 | P | A | 5,000 | $16.51 | 1,480,097 | D | — | — | (F1) Represents the purchase price paid by the Reporting Person for the shares of common stock, $0.001 par value per share, of the Registrant, in an open market transaction. |